12:00 AM
 | 
Aug 20, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

MultiCell Technologies preclinical data

In vitro, MCT-485 showed dose-related cytotoxicity in several human HCC cell lines. The compound also induced...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >